Cite
Rosenstein ED, Advani S, Reitz RE, et al. The prevalence of insulin receptor antibodies in patients with systemic lupus erythematosus and related conditions. J Clin Rheumatol. 2001;7(6):371-3doi: 10.1097/00124743-200112000-00004.
Rosenstein, E. D., Advani, S., Reitz, R. E., & Kramer, N. (2001). The prevalence of insulin receptor antibodies in patients with systemic lupus erythematosus and related conditions. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 7(6), 371-3. https://doi.org/10.1097/00124743-200112000-00004
Rosenstein, E D, et al. "The prevalence of insulin receptor antibodies in patients with systemic lupus erythematosus and related conditions." Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases vol. 7,6 (2001): 371-3. doi: https://doi.org/10.1097/00124743-200112000-00004
Rosenstein ED, Advani S, Reitz RE, Kramer N. The prevalence of insulin receptor antibodies in patients with systemic lupus erythematosus and related conditions. J Clin Rheumatol. 2001 Dec;7(6):371-3. doi: 10.1097/00124743-200112000-00004. PMID: 17039177.
Copy
Download .nbib